Contemporary trends in cardiac rehabilitation in Germany: Patient characteristics, drug treatment, and risk-factor management from 2000 to 2005

European Journal of Preventive Cardiology

Volumn 15, Issue 3, 2008, Pages 312-318

  Bestehorn, Kurt ^a,b   Wegscheider, Karl ^c   Völler, Heinz ^d  

^a MSD Sharp and Dohme GmbH   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d Klinik Am See   (Germany)

Author keywords

cardiac rehabilitation; centre variability; drug treatment; inpatients; risk factors; secular trends

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ANTILIPEMIC AGENT; CARDIOVASCULAR AGENT;

ADULT; ARTICLE; BLOOD PRESSURE REGULATION; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DATA BASE; DEMOGRAPHY; DIET RESTRICTION; FEMALE; GERMANY; HEART REHABILITATION; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; REGISTRATION; RISK FACTOR; AGED; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDY; HOSPITALIZATION; MIDDLE AGED; PATHOPHYSIOLOGY; REGISTER; REHABILITATION CENTER; STATISTICS; TREATMENT OUTCOME;

ADULT; AGED; ANTILIPEMIC AGENTS; CARDIOVASCULAR AGENTS; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; GERMANY; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; REGISTRIES; REHABILITATION CENTERS; RISK FACTORS; TREATMENT OUTCOME;

EID: 56149118166     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1097/HJR.0b013e3282f40e14     Document Type: Article

References (23)

1. Oldridge NB, Guyatt GH, Fischer ME, Rimm AA. Cardiac rehabilitation after myocardial infarction. Combined experience of randomized clinical trials. JAMA 1988; 260: 945–950.
2. O'Connor GT, Buring JE, Yusuf S, Goldhaber SZ, Olmstead EM, Paffenbarger RS Jr et al. An overview of randomized trials of rehabilitation with exercise after myocardial infarction. Circulation 1989; 80: 234–244.
3. Taylor RS, Unal B, Critchley JA, Capewell S. Mortality reductions in patients receiving exercise-based cardiac rehabilitation: how much can be attributed to cardiovascular risk factor improvements? Eur J Cardiovasc Prev Rehabil 2006; 13: 369–374.
4. Karoff M, Held K, Bjarnason-Wehrens B. Cardiac rehabilitation in Germany. Eur J Cardiovasc Prev Rehabil 2007; 14: 18–27.
5. Willich SN, Muller-Nordhorn J, Kulig M, Binting S, Gohlke H, Hahmann H et al. Cardiac risk factors, medication, and recurrent clinical events after acute coronary disease: a prospective cohort study. Eur Heart J 2001; 22: 307–313.
6. Ottenbacher KJ, Smith PM, Illig SB, Linn RT, Ostir GV, Granger CV. Trends in length of stay, living setting, functional outcome, and mortality following medical rehabilitation. JAMA 2004; 292: 1687–1695.
7. Richardson LA, Buckenmeyer PJ, Bauman BD, Rosneck JS, Newman I, Josephson RA. Contemporary cardiac rehabilitation: patient characteristics and temporal trends over the past decade. J Cardiopulm Rehabil 2000; 20: 57–64.
8. Cardiac rehabilitation programs. A statement for healthcare professionals from the American Heart Association. Circulation 1994; 90: 1602–1610.
9. Leon AS, Franklin BA, Costa F, Balady GJ, Berra KA, Stewart KJ et al. Cardiac rehabilitation and secondary prevention of coronary heart disease: an American Heart Association scientific statement from the Council on Clinical Cardiology. Circulation 2005; 111: 369–376.
10. Smith SC Jr, Blair SN, Bonow RO, Brass LM, Cerqueira MD, Dracup K et al. AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update. Circulation 2001; 104: 1577–1579.
11. The Peace Trial Investigators. Angiotensin-converting-enzyme inhibition in stable coronary artery disease. N Engl J Med 2004; 351: 2058.
12. Ruof J, Klein G, Marz W, Wollschlager H, Neiss A, Wehling M. Lipid-lowering medication for secondary prevention of coronary heart disease in a German outpatient population: the gap between treatment guidelines and real life treatment patterns. Prev Med 2002; 35: 48–53.
13. Bohler S, Scharnagel H, Freisinger F, Stojakovic T, Glaesmer H, Klotsche J et al. Unmet needs in the diagnosis and treatment of dyslipidemia in the primary care setting in Germany. Atherosclerosis 2006 (doi:10.1016/j.atherosclerosis.2006.02.025).
14. Pittrow D, Stalla GK, Zeiher AM, Silber S, Marz W, Pieper L et al. Prevalence, drug treatment and metabolic control of diabetes mellitus in primary care. Med Klin (Munich) 2006; 101: 635–644.
15. Sharma A, Wittchen H, Kirch W, Pittrow D, Ritz E, Göke B et al. High prevalence and poor control of hypertension in primary care: cross sectional study. J Hypertens 2004; 22: 479–486.
16. Pittrow D, Kirch W, Bramlage P, Lehnert H, Hofler M, Unger T et al. Patterns of antihypertensive drug utilization in primary care. Eur J Clin Pharmacol 2004; 60: 135–142.
17. Phillips L, Branch W, Cook C, Doyle J, El-Kebbi I, Gallina D et al. Clinical inertia. Ann Intern Med 2001; 135: 825–834.
18. EUROASPIRE II Study Group. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme. Eur Heart J 2001; 22: 554–572.
19. Bjarnason-Wehrens B, Grande G, Loewel H, Voller H, Mittag O. Gender-specific issues in cardiac rehabilitation: do women with ischaemic heart disease need specially tailored programmes? Eur J Cardiovasc Prev Rehabil 2007; 14: 163–171.
20. Mittag O. Findings on gender differences in the quality of care in cardiac rehabilitation: are women discriminated against? Rehabilitation (Stuttg) 2003; 42: 204–210.
21. Grande G, Leppin A, Romppel M, Altenhoner T, Mannebach H. Women and men after acute myocardial infarction: are there gender differences in participation rates in cardiac rehabilitation? Rehabilitation (Stuttg) 2002; 41: 320–328.
22. Muller-Nordhorn J, Kulig M, Binting S, Voller H, Krobot KJ, Willich SN. Regional variation in medication following coronary events in Germany. Int J Cardiol 2005; 102: 47–53.
23. McMullan R, Silke B, Bennett K, Callachand S. Resource utilisation, length of hospital stay, and pattern of investigation during acute medical hospital admission. Postgrad Med J 2004; 80: 23–26.